Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CZ1S for Injection for postoperative analgesia after total knee arthroplasty (phase III)
CTR20251869Phase 3Completed
- Sponsor
- Zhejiang Cuize Pharmaceutical Technology
- Start
- May 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of CZ1S in postoperative pain, sponsored by Zhejiang Cuize Pharmaceutical Technology. Started May 2025; status: completed.
02
Drugs
CZ1S
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20251869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251869.